A CDC study published in JAMA Internal Medicine on Monday found that primary care providers are prescribing antibiotics for sinus infections longer than recommended by clinical practice guidelines. A key antibiotic stewardship principle is to use the shortest effective length of antibiotics recommended by guidelines in order to fight the growing problem of antibiotic resistance.
A CDC study published in JAMA Internal Medicine on Monday found that primary care providers are prescribing antibiotics for sinus infections longer than recommended by clinical practice guidelines.
A key antibiotic stewardship principle is to use the shortest effective length of antibiotics recommended by guidelines in order to fight the growing problem of antibiotic resistance. In the report, the CDC said that antibiotic stewardship programs can ensure that treatment adheres to these guidelines.
According to the CDC, at least 2 million people become infected with bacteria that are resistant to antibiotics each year. Additionally, at least 23,000 people die as a direct result of these infections, and many more die from other conditions that were complicated by an antibiotic-resistant infection. Last year, The Joint Commission put in place an antimicrobial stewardship standard for institutions to follow.
Antibiotics are prescribed more for sinus infections than for any other illness. The CDC study focused on an estimated 3.7 million visits (95% CI, 3,124,279-4,269,673) at which antibiotic therapy was prescribed for sinusitis that met the study criteria. More than two-thirds (69.6%) of antibiotic prescriptions, and 91.5% of non-azithromycin antibiotic prescriptions, were for 10 days or longer, even though the Infectious Diseases Society of America recommends 5 to 7 days of therapy for uncomplicated cases of sinusitis.
In addition, more than 20% of antibiotic prescriptions for sinus infections were for 5 days of azithromycin, even though guidelines recommend against prescribing azithromycin because of high rates of existing resistance to this drug and others in its class.
No penicillin or tetracycline prescriptions were for 5-day courses, and only 5% of antibiotic prescriptions were for 7-day courses of penicillins, tetracyclines, or fluoroquinolones.
According to the authors, although 7- to 10-day courses are recommended for patients at high risk or whose initial treatment has failed, it is unlikely that such cases represent the majority of patients captured in the study. They cited previous work that has shown that shorter durations (3-7 days) of antibiotics have been associated with similar outcomes and fewer drug-related adverse events compared with longer durations (6-10 days).
The study has limitations, the authors said. They were not able to account for underlying conditions or other indicators that may have called for a longer course of antibiotics. Because visits with a diagnosis of unspecified sinusitis were excluded from the analysis, some cases of acute sinusitis may have been missed. However, the findings of a sensitivity analysis that included cases of both acute and unspecified sinusitis were similar.
Reference
King LM, Sanchez GV, Bartoces M, Hicks LA, Fleming-Dutra KE. Antibiotic therapy duration in US adults with sinusitis [published online March 26, 2018]. JAMA Intern Med. doi: 10.1001/jamainternmed.2018.0407.
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Government agencies have created an online portal for the public to report potential anticompetitive practices in health care; there are changes coming to the “boxed warning” section for chimeric antigen receptor T-cell therapies (CAR T) to highlight T-cell blood cancer risk; questions about the safety of obesity medications during pregnancy have arisen in women on them who previously struggled with fertility issues.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen
Gene, Light Therapy Combo Shows Promise Against Prostate Cancer Cells in Proof-of-Concept Study
April 18th 2024In their preclinical model, the researchers found efficacy both in vitro and in vivo by using CRISPR-Cas9 to mimic porphyria and combining the technology with light therapy.
Read More